Frontier IP (GB:FIPP) has released an update.
Frontier IP’s portfolio company, The Vaccine Group, has secured an Innovate UK Smart grant worth over £400,000 to advance vaccine development for cattle using their novel herpesvirus-based platform. This initiative targets significant diseases like bovine respiratory syncytial virus and lumpy skin disease, with the potential to revolutionize vaccine efficacy and economic outcomes in livestock farming. Frontier IP’s 17% stake in The Vaccine Group underscores its strategic investment in groundbreaking biotechnologies.
For further insights into GB:FIPP stock, check out TipRanks’ Stock Analysis page.
